Zonagen divests Fertility Technologies:
This article was originally published in Clinica
Executive Summary
Zonagen, a reproductive health, sexual dysfunction and urologic pharmaceuticals company has sold its wholly-owned Fertility Technologies to SAGE BioPharma. The Woodlands, Texas-based Fertility Technologies markets and distributes a number of diagnostics and devices involved in so-called assisted reproductive technique procedures. The terms of the sale were not disclosed, although Zonagen said that the subsidiary was sold as it did not represent Zonagen's core business of drug discovery.